FAQ

Common side effects include nausea, diarrhea, vomiting, decreased appetite, indigestion, and a risk of low blood sugar, especially when taken with other diabetes medications.

Yes, Victoza carries a boxed warning about the risk of thyroid C-cell tumors, including medullary thyroid carcinoma, based on animal studies. Although it's not confirmed in humans, you should be vigilant for symptoms like neck swelling or difficulty swallowing.

While not approved specifically for weight loss, Victoza may lead to weight loss as a secondary effect. This is due to its ability to increase insulin secretion and decrease appetite.

Before opening, Victoza pens should be stored in the refrigerator. Once in use, it can be kept at room temperature or in the refrigerator. Avoid exposing the pen to excessive heat or sunlight.

If you miss a dose, take it as soon as you remember if it's within 12 hours of the missed dose. If more than 12 hours have passed, skip the missed dose and take your next dose at the regular scheduled time.

Yes, Victoza has been linked to a risk of pancreatitis. If you experience severe abdominal pain that may radiate to your back, contact your healthcare provider immediately.

Yes, Victoza can be taken with other diabetes medications, but it may increase the risk of hypoglycemia. Your doctor might adjust your medication regimen accordingly.

The safety of Victoza during pregnancy hasn't been established. If you are pregnant or planning to become pregnant, discuss with your healthcare provider the best way to manage your diabetes during pregnancy.

Emtriva (emtricitabine) is an antiviral medication used in combination with other HIV medications to help control HIV infection. It helps decrease the amount of HIV in your body so your immune system can work better.

Emtriva is available in capsule and oral solution forms. It is taken once daily, with or without food. The dosage may vary based on the patient's age, weight, and renal function.